US Pharma MarketingKeytruda made Merck an oncology powerhouse, but as the patent cliff looms, its business development leader outlines what’s next.
Merck is pharma’s most patent-exposed company. Now it’s reinventing itself.
Merck is pharma’s most patent-exposed company. Now it’s reinventing itself. is a pharma and life sciences industry update from PharmaVoice. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.
Source: PharmaVoice